PMCPA Case Library

Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.

1,930
Cases
291
Companies
154
Clauses
6
Code Versions

or browse all 154 ABPI clause guides ↗

Case Library Membership

Filter by Company & ABPI Clause

Search free — but unlock advanced filters to find every case involving a specific company or clause.

Filter 1,930+ cases by any of 291 companies
Filter by any of 154 ABPI Code clauses
Filter by Code version (2016, 2019, 2021…)
Full-text keyword search across all cases
Cancel any time

Already a member? Sign in →

Case Library Membership

Best value
£249 /year Save £99

inc. VAT

£29 /month

inc. VAT · cancel any time

Unlock Full Access →

Secure payment via Stripe


Need access for your team?

Company licences available for compliance teams, medical affairs, and training programmes.

Get a team quote →

1,930 cases found

08
Mar 2026
2021 Code AstraZeneca

AUTH/3832/10/23: AstraZeneca CKD education video on SGLT2 inhibitors – no breach

Complaint alleged a CKD management video indirectly promoted Forxiga via SGLT2 inhibitor references and lacked PI/AE statements. Panel found the content balanced,…

08
Mar 2026
2021 Code Moderna Biotech UK Clause 2 Clause 5.1 Clause 11.1 Clause 11.2 Clause 19.1

Moderna: Madrid “advisory board” ruled promotional; unlicensed/off-SPC vaccine content and inducement concerns (AUTH/3783/6/23)

Global advisory board in Madrid with a UK HCP was ruled not genuine. Panel found promotion of an investigational RSV vaccine and…

08
Mar 2026
2021 Code GSK Clause 5.1 Clause 11.2 Clause 26.1 Clause 26.2

GSK press release on dostarlimab EAMS found promotional to the public and for an unlicensed indication (AUTH/3803/07/23)

PMCPA ruled GSK’s EAMS press release for dostarlimab was promotional, sent to mainstream media, and promoted an unlicensed indication. Breaches: 5.1, 11.2,…

08
Mar 2026
2021 Code Moderna

AUTH/3790/7/23: Ex-employee v Moderna (preprint data in presentations) — No breach

Anonymous ex-employee alleged Moderna misused preprint vaccine effectiveness data, cherry-picked graphs and sought UK contract advantage via JCVI presentations. Panel found no…

08
Mar 2026
2021 Code Novartis

Novartis: GP alleged caller implied NHS England identity during promotional call (AUTH/3824/09/2023) – No breach

A GP alleged a caller acting for Novartis implied they were NHS England and only disclosed Novartis when challenged. Panel could not…

08
Mar 2026
2021 Code Moderna

AUTH/3791/7/23: Complainant v Moderna — whistleblowing processes and alleged off-label promotion (No breach)

Anonymous complaint alleged inadequate whistleblowing processes and potential off-label promotion via a Moderna US webcast. Panel found the complainant did not prove…

08
Mar 2026
2021 Code Daiichi Sankyo

AUTH/3776/6/23: Complainant v Daiichi Sankyo — patient organisation cholesterol programme (no breach)

Complaint alleged a patient organisation guideline was promotional for Nilemdo/Nustendi and lacked contraindication detail, PI and certification. Panel found Daiichi Sankyo not…

08
Mar 2026
2021 Code AstraZeneca

AUTH/3842/10/23: Fluenz Tetra ‘Post-Administration Information’ leaflet – alleged missing SmPC safety points (No breach)

A health professional alleged AstraZeneca’s Fluenz Tetra post-administration booklet omitted two SmPC safety requirements. Panel found the points were covered pre-administration and…

08
Mar 2026
2021 Code GSK UK Clause 8

GSK: Responsive disease-awareness website breached Clause 8.3 due to uncertified desktop vs mobile final forms (AUTH/3819/9/23)

PMCPA found GSK’s Tackle Meningitis site showed substantive desktop vs mobile differences on two pages. Each final form should have been certified…

08
Mar 2026
2021 Code AstraZeneca

AUTH/3817/9/23: AstraZeneca SENTINEL Plus website and MART references — no breach

Complaint alleged MART references on AstraZeneca’s SENTINEL Plus HCP website indirectly promoted Symbicort and therefore needed PI and an AE reporting statement.…

08
Mar 2026
2021 Code AstraZeneca Clause 5.1 Clause 6.1

AstraZeneca breached Clauses 6.1 and 5.1 after Calquence dosing leaflet omitted monitoring caveat for moderate hepatic impairment (AUTH/3846/11/23)

Calquence “How to dose” leaflet said no dose adjustment for moderate hepatic impairment but omitted SmPC caveat to closely monitor for toxicity.…

08
Mar 2026
2021 Code GSK UK Clause 6

GSK value.gsk COPD landing page: charts misleading because asthma data caveat was hidden in a dropdown (Clause 6.1 breach)

GSK’s COPD optimisation landing page included charts where LAMA data also reflected asthma. The caveat was only visible via a dropdown, so…

08
Mar 2026
2021 Code Proveca

AUTH/3812/8/23: Proveca – Google search results for Sialanar and alleged public advertising (No breach)

Complaint alleged Proveca’s Sialanar pages were promoted via Google/SEO and inaccessible to the public. Panel found search results reflected Google indexing, HCP…

08
Mar 2026
2021 Code GSK

AUTH/3823/9/23: GSK LinkedIn ‘likes’ on US momelotinib approval posts – no breach (Clauses 12.1, 12.10, 26.1)

Complaint alleged GSK staff ‘likes’ on LinkedIn posts about US FDA approval of momelotinib promoted a POM to the UK public without…

08
Mar 2026
2021 Code Daiichi Sankyo UK

AUTH/3820/9/23: Complainant v Daiichi Sankyo (AI recording of HCP calls) – No breach

Anonymous complaint alleged Daiichi Sankyo covertly recorded HCP calls using an AI tool. Panel found no evidence of covert recording and accepted…

13456789129

Ask questions about any PMCPA case

Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free